Search

Headquarters

Contact Us

  • (+01) 512 835 8026
  • 3300 Duval Road
    Austin, TX 78759
    USA
  • Mon to Fri - 8:50am to 5:00pm

Ready to order?

Great! Every order starts with a quote.

Get Started 

  • (+01) 512 835 8026
  • Email Us
Get a Quote Contact | FAQ's | Blog
Rules-Based Medicine Rules-Based Medicine

a Q<sup>2</sup> Solutions Company

Toggle menu

Skip to content
  • About Us
    • About RBM

      Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA certified, multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services.
    • About RBM

      • About Us
      • Our Scientists
      • Quality Policy
      • Employment
      • Partners
      • Sales Team
      • Certifications
    • Newsroom

      • Press
      • Company Newsletters
      • Conferences
      • Abstracts + Papers
      • Sign Up for Our Newsletter
      • Blog
    • Data Quality

      • Overview
      • RBM Technology
  • Biomarker Solutions
    • Solutions

      • Overview
      • Assay Change Log

      CustomMAP

      If a smaller, more focused panel of analytes is required, we can build a Custom MAP to meet your needs.

      Learn More »

      TruCulture Spike

    • Multiplexed Immunoassays

      • NEW! Idiopathic Pulmonary Fibrosis (IPF) Biomarkers
      • Full Biomarker Menu
      • DiscoveryMAP® v. 4.0
      • ExplorerMAP™ v. 1.0
      • HumanMAP® v. 2.0
      • CardiovascularMAP® v. 3.0
      • AngiogenesisMAP® v. 1.0
      • InflammationMAP® v. 1.1
      • ImmunoMAP® v. 1.0
      • MetabolicMAP® v. 1.0
      • KidneyMAP®
      • CytokineMAP A
      • CytokineMAP B
      • SARS-CoV-2/COVID-19 Research
      • Cytokine Storm Testing for SARS-CoV-2/COVID-19 Research
    • TruCulture

      Whole Blood Collection and Culture System

      Learn More »
      Quanterix simoa

      Ultrasensitive immunoassays manufactured by RBM and based on Quanterix’s Simoa technology.

      Learn More »
  • Resources + Support
    • Resources

      • Bibliography
      • White Papers
      • Application Notes
      • Events
      • Webinars
      • Blog
      • COVID-19/SARS-CoV-2 Research Tools
    • Support

      • Client Services
      • Request a Biomarker
      • Speak to a Scientist
  • How to Order
    • Ordering Information

      • How to Order
      • Request a quote
      • Acceptable Samples
      • Frequently Asked Questions
    • Request Information

      • Contact Client Services
      • Request a Biomarker
      • Speak to a Scientist
    • Ready to Order?

      Great!

      Every order starts with a quote.

      Get Started

Category Archives: Blog

13 Feb 2020

Biomarker Panels Used to Predict Renal Function in Type I Diabetes

February 13, 2020
Desiree Klingler-Gaston
Blog, Diabetes, Renal Function and Toxicity, Utilized Rules-Based Medicine's Services
In a study published in Diabetologia1, researchers compared blood and urine-based biomarker panels to determine if they can outperform current eGFR se...
Read More
8 Jan 2020

Serum Biomarker Signature Correlates With Cancer Drug Clearance and Predicts Overall Survival

January 8, 2020
Desiree Klingler-Gaston
Blog, Cancer, Technology- Multi-Analyte Profile, Utilized Rules-Based Medicine's Services
In a study published in the Journal for ImmunoTherapy of Cancer December 2019 issue1, researchers demonstrate that a baseline serum biomarker signatur...
Read More
19 Nov 2019

Promising Rapid, Blood Diagnosis Test for Tuberculosis Identified 1

November 19, 2019
Desiree Klingler-Gaston
Blog, Utilized Rules-Based Medicine's Services
Tuberculosis is a treatable disease that continues to kill millions of people globally. Most infected people live in regions where a timely diagno...
Read More
24 Sep 2019
TruCulture - Immunomonitoring Made Simple

Tools to Profile Human Immunity

September 24, 2019
Desiree Klingler-Gaston
Blog, Utilized Rules-Based Medicine's Services
At Immunology 2019, Myriad RBM exhibited a poster, “Combining TruCulture® and OptiMAP to Profile Human Immunity."  It details the immune responses (cy...
Read More
14 Jan 2019
Serum tube

Inflammatory Markers Can Identify Non-Responders to Dendritic Vaccine

January 14, 2019
Rules-Based Medicine
Cancer, Cytokines and Chemokines, Inflammation
(Note: While the authors stated serum in the publication, the blood samples were collected in EDTA tubes. Thus, in the following summary, serum is cor...
Read More
16 Oct 2018
KIM-1 Kidney Injury Molecule biomarker

KIM-1 & β2-M Predict Rapid Decline in Type 2 Diabetes Renal Function

October 16, 2018
Rules-Based Medicine
Diabetes, Renal Function and Toxicity
Serum Kidney Injury Molecule 1 and &beta;2-Microglobulin Perform as well as Larger Biomarker Panels for Prediction of Rapid Decline in Renal Funct...
Read More
17 Aug 2018
Quality Control worksheet

Cytokines, Hemodynamic Parameters, & Clinical Outcomes in PAH

August 17, 2018
Rules-Based Medicine
Cardiac, Cytokines and Chemokines, Inflammation
Aditya A. Joshi, Ryan Davey, Youlan Rao, Kai Shen, Raymond L. Benza, Amresh Raina Read Full Article » Pulmonary arterial hypertension (PAH) is a r...
Read More
1 2 3 4 … 20

Categories

  • Biomarkers (4)
  • Blog (134)
    • Autoimmune and Arthritis (10)
    • Cancer (28)
    • Cardiac (9)
    • Cytokines and Chemokines (20)
    • Diabetes (7)
    • Gastrointestinal (1)
    • Inflammation (42)
    • Neuroscience and Neurological (33)
    • News From the Lab (1)
    • Renal Function and Toxicity (8)
    • Technology- Multi-Analyte Profile (1)
    • TruCulture (2)
  • COVID-19 (1)
  • Press (37)
  • Utilized Rules-Based Medicine's Services (43)

ABOUT RBM

Overview
Our Scientists
Quality Policy
Employment
Partners
Sales Team
Certifications

A Q2 Solutions Company

Contact Us

Q2 Solutions, a wholly owned subsidiary and laboratory division of IQVIA, is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository and specimen management, and clinical trial sample and consent tracking solutions. Learn more at www.q2labsolutions.com.

MAPs

Full Biomarker Menu
DiscoveryMAP® v. 3.3
ExplorerMAP™ v. 1.0
HumanMAP® v. 2.0
CardiovascularMAP® v. 3.0
AngiogenesisMAP® v. 1.0
InflammationMAP® v. 1.0
ImmunoMAP® v. 1.0
NeuroMAP™ v. 1.0
MetabolicMAP® v. 1.0
KidneyMAP®
CytokineMAP A
CytokineMAP B

RESOURCES

Bibliography
White Papers
Events
Webinars
Blog

SUPPORT

Customer Support
Speak to a Scientist
Assay Change Log
Request a Biomarker
FAQs

SOLUTIONS

Results Processing
Assay Development
Quality Control
Project Management

SERVICES

Multiplexed Assay Services
Ultrasensitive Assays
TruCulture

  • Jobs
  • Terms of Use
  • Privacy Practice
  • Analytes Listing
Copyright © 2023 Rules-Based Medicine. All rights reserved. RBM does not sell your personal information